Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jo Chien

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
The Lancet. Oncology|February 15, 2016
HER2-positive breast cancer: is more treatment better?Hope S Rugo, A Jo Chien
Seminars in Oncology|May 3, 2008
Cellular mechanisms of resistance to anthracyclines and taxanes in cancer: intrinsic and acquiredA Jo Chien, Mark M Moasser
Breast Cancer Research and Treatment|November 13, 2012
Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancerA Jo Chien, Hope S Rugo
Current Breast Cancer Reports|April 22, 2024
Impact of Systemic Therapy on Fertility in Women with Early-Stage Breast CancerKelsey H Natsuhara, A Jo Chien
Expert Opinion on Drug Safety|February 24, 2010
The cardiac safety of trastuzumab in the treatment of breast cancerA Jo Chien, Hope S Rugo
Cancer Treatment and Research|July 14, 2009
Lapatinib: new directions in HER2 directed therapy for early stage breast cancerA Jo Chien, Hope S Rugo
Cell Reports. Medicine|June 22, 2022
Optimizing hormone therapy for breast cancer: Translating gains to the early-stage settingA Jo Chien, Beverly Kyalwazi, Laura J Esserman
Breast Cancer Research and Treatment|October 30, 2021
Emerging immunotherapeutic strategies for the treatment of breast cancerLaura A Huppert, Veronica Mariotti, A Jo Chien, et al.
NPJ Breast Cancer|June 27, 2019
A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxelSorbarikor Piawah, Colby Hyland, Sarah E Umetsu, et al.
JCO Oncology Practice|September 10, 2020
Multidisciplinary Management of Cancer During PregnancyJordyn Silverstein, Annalisa L Post, A Jo Chien, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
The Lancet. Oncology|February 15, 2016
HER2-positive breast cancer: is more treatment better?Hope S Rugo, A Jo Chien
Seminars in Oncology|May 3, 2008
Cellular mechanisms of resistance to anthracyclines and taxanes in cancer: intrinsic and acquiredA Jo Chien, Mark M Moasser
Breast Cancer Research and Treatment|November 13, 2012
Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancerA Jo Chien, Hope S Rugo
Current Breast Cancer Reports|April 22, 2024
Impact of Systemic Therapy on Fertility in Women with Early-Stage Breast CancerKelsey H Natsuhara, A Jo Chien
Expert Opinion on Drug Safety|February 24, 2010
The cardiac safety of trastuzumab in the treatment of breast cancerA Jo Chien, Hope S Rugo
Cancer Treatment and Research|July 14, 2009
Lapatinib: new directions in HER2 directed therapy for early stage breast cancerA Jo Chien, Hope S Rugo
Cell Reports. Medicine|June 22, 2022
Optimizing hormone therapy for breast cancer: Translating gains to the early-stage settingA Jo Chien, Beverly Kyalwazi, Laura J Esserman
Breast Cancer Research and Treatment|October 30, 2021
Emerging immunotherapeutic strategies for the treatment of breast cancerLaura A Huppert, Veronica Mariotti, A Jo Chien, et al.
NPJ Breast Cancer|June 27, 2019
A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxelSorbarikor Piawah, Colby Hyland, Sarah E Umetsu, et al.
JCO Oncology Practice|September 10, 2020
Multidisciplinary Management of Cancer During PregnancyJordyn Silverstein, Annalisa L Post, A Jo Chien, et al.
Pageof 7